medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2007, Número 4

<< Anterior Siguiente >>

Arch Neurocien 2007; 12 (4)


Polirradiculoneuropatía crónica inflamatoria desmielinizante

Castro MJI, Briceño GE

Idioma: Español
Referencias bibliográficas: 65
Paginas: 221-228
Archivo PDF: 94.82 Kb.


RESUMEN

La polirradiculoneuropatía crónica inflamatoria desmielinizante es potencialmente tratable pero es con frecuencia subdiagnosticada. Se caracteriza por debilidad simétrica, progresiva y alteraciones sensitivas y autonómicas con aumento de proteínas en el líquido cefalorraquídeo constituye un 20% de neuropatía no diagnosticada. Se puede asociar con otras enfermedades concurrentes. Se estudiaron durante un periodo de 10 años. 26 pacientes que cumplían los criterios fueron incluidos con edad entre 15 a 71 años. Se dio tratamiento con prednisona con mejoría parcial en 13, asintomáticos 5, sin mejoría 4.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Koller H, Kieseier BC, Jander S, Hartung HP. Chronic inflammatory demyelinating polyneuropathy. N Engl J Med 2005; 352(13): 1343-56.

  2. Dalakas MC, Engel WK. Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol 1981;9: Suppl:134-45.

  3. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR. Chronic inflammatory demyelinating polyradiculoneuropathy: clinical characteristics, course, and recommendations for diagnostic criteria. Arch NeuroI 1989;46:878-84.

  4. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP): report from an ad hoc subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991; 41:617-8.

  5. Connolly AM. Chronic inflammatory demyelinating polyneuropathy in childhood. Pediatr Neurol 2001;24:177-82.

  6. Koul R, Chacko A, Javed H, AI-Hinai K, Zachariah M, Bulusu S. A profile of childhood neuropathies at auniversity hospital in Oman. Saudi Med J. 2002 Apr;23(4):450-6.

  7. McLeod JG, Pollard JD, Macaskill P, Mohamed A, Spring P, Khurana V. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol 1999;46:910-3.

  8. Lunn MP, Manji H, Choudhary PP, Hughes RA, Thomas PK. Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry 1999;66:677-80.

  9. Barohn RJ, Saperstein DS. Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. Semin NeuroI 1998;18: 49-61.

  10. Corona-Vazquez T, Campillo-Serrano C, Lopez M, Mateos-G JH, Soto-Hernandez JL. The neurologic diseases. Gac Med Mex 2002;138(6):533-46.

  11. Saperstein DS, Katz JS, Amato AA, Barohn RJ. Clinical spectrum of chronic acquired ndemyelinating polyneuropathies. Muscle Nerve 2001;24:311-24.

  12. Latov N. Diagnosis of CIDP. Neurology 2002;59:Suppl 6:52-56.

  13. Sander HW, Latov N. Research criteria for defining patients with CIDP. Neurology 2003;60:Suppl 3:58-515.

  14. McCombe PA, Pollard JD, McLeod JG. Chronic inflammatorydemyelinating polyradiculoneuropathy. Brain 1987;110: 1617-30.

  15. Bouchard E, Lacroix C, Plante’ V. Clinicopathological findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 1999;52:498-503.

  16. Rajabally YA, Jacob S, Abbott RJ. Clinical heterogeneity in mild chronic inflammatory demyelinating polyneuropathy. Eur J Neurol 2006 Sep;13(9):958-62.

  17. Jann S, Beretta S, Bramerio MA. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment. Muscle Nerve 2005; 32(3):351-6.

  18. Kuwabara S, Ogawara K, Misawa S, Mori M, Hattori T. Distribution patterns of demyelination correlate with clinical profiJes in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 2002 Jan;72(1):37-42.

  19. Mygland A, Monstad P. Chronic acquired demyelinating symmetric polyneuropath classified by pattern of weakness. Arch Neurol 2003;60:260-4.

  20. Pestronk A. Multifocal motor neuropathy: diagnosis and treatment. Neurology 1998;51:Suppl 5:S22-S24.

  21. Viala K, Renie L, Maisonobe T. Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome. Brain 2004;127:2010-7.

  22. Uncini A, Di Muzio A, De Angelis MV, Gioia S, Lugaresi A. Minimal and asymptomatic chronic inflammatory demyelinating polyneuropathy. Clin Neurophysiol 1999;110(4):694-8.

  23. Albert LJ, Inman RD. Mechanisms of disease: molecular mimicry and autoimmunity. Engl J Med 1999; 341:2068-74.

  24. Rousseau A, Salachas F, Baccard M, Delattre JY, Sanson M. Chronic inflammatory polyneuropathy revealing malignant melanoma. J Neurooncol 2005;71(3):335-6.

  25. Weiss MD, Luciano CAl, Semi no-Mora C, Dalakas MC, Quarfes RH. Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma. Neurology 1998;51(6):1738-41.

  26. Schmidt B, Toyka KV, Kiefer R, Full J, Hartung HP, Pollard J. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve 1996; 19:474-87.

  27. Winer J, Hughes S, Cooper J, Ben-Smith A, Savage CT. Cells infiltrating sensory nerve biopsies from patients with inflammatory neuropathy. J Neurol 2002;249:616-21.

  28. IIIes Z, Kondo T, Newcombe J, Oka N, Tabira T, Yamamura T. Differential expression of NK T cell Vü24JerQ invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J Immunol 2000;164:4375-81.

  29. IIIes Z, Shimamura M, Newcombe J, Oka N, Yamamura T. Accumulation of Vü7.2-Jcr-33 invariant T cells in human autoimmune inflammatory lesions in the nervous system. Int Immunol 2004;16:223-30.

  30. Bosboom WM, Van den Berg LH, Mollee I. Sural nerve T-cell receptor V_ gene utilization in chronic inflammatory demyelinating polyneuropathy and vasculitic neuropathy. Neurology 2001;56:74-81.

  31. Lombardi R, Erne B, Lauria G, Pareyson D, Borgna M, Morbin M. IgM deposits on skin nerves in anti-myelin- associated glycoprotein neuropathy. Ann Neurol 2005 Feb;57(2):180-7.

  32. Dalakas MC, Engel WK. Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy. Arch Neurol 1980;37:637-40.

  33. Dalakas MC, Houff SA, Engel WK, Madden DL, Sever JL. CSF “monoclonal” bands in chronic relapsing polyneuropathy. Neurology 1980;30:864-7.

  34. Yan WX, Taylor J, Andrias-Kauba S, Pollard JD. Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients. Ann Neurol 2000;47:765-75.

  35. Yan WX, Archelos JJ, Hartung HP, Pollard JD. Po protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001;50: 286-92.

  36. Melendez-Vasquez C, Redford J, Choudhary PP. Immunological investigation of chronic intlammatory demyelinating polyradiculoneuropathy. J Neuroimmunol 1997.

  37. Allen D, Giannopoulos K, Gray I, Gregson N, Makowska A, Pritchard J. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 2005;10(2):174-80.

  38. Haq RU, Pendlebury WW, Fries TJ, Tandan R. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients. Muscle Nerve 2003;27(4):465-70.

  39. Gorson KC, Ropper AH, Adelman LS, Weinberg DH. Intluence of diabetes mellitus on chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2000;23:37-43.

  40. Hatano T, Fukuda M, Shiotsuki H, Miwa H, Urabe T, Mizuno Y. Chronic inflammatory demyelinating polyneuropathy followed by systemic lupus erythematosus and Sjogren syndrome: a case report Rinsho Shinkeigaku 2006;46(3):203-9.

  41. Cocito D, Durelli L, Isoardo G. Different clinical, electrophysiological and immunological features of CIDP associated with paraproteinaemia. Acta Neurol Scand 2003; 108(4):274-80.

  42. Simmons Z, Albers JW, Bromberg MB, Feldman EL. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy. Neurology 1993; 43(11):2202-9.

  43. Rajabally Y, Vital A, Ferrer X, Vital C, Julien J, Latour P, et al. Chronic inflammatory demyelinating polyneuropathy caused by HIV infection in a patient with asymptomatic CMT lA. J Peripher Nerv Syst 2000;5(3):158-62.

  44. Simmons Z, Albers JW, Bromberg MB, Feldman EL. Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy. Brain. 1995;118 ( Pt 2):359-68.

  45. Krivickas LS, Hochberg FH, Freeman S. Chronic inflammatory demyelinating polyradiculoneuropathy with tumefactive central demyelination. Muscle Nerve 2006;33(2):283-8.

  46. Laura M, Leong W, Murray NM, Ingle G, Miszkiel KA, Altmann DR, Miller DH, Reilly MM. Chronic inflammatory demyelinating polyradiculoneuropathy: MRI study of brain and spinal cord. Neurology 2005;64(5):914-6.

  47. Matsuoka N/ Kohriyama T, Ochi K, Nishitani M, Sueda Y, Mimori Y, Nakamura S, Matsumoto M. Detection of cervical nerve root hypertrophy by ultrasonography in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Sci 2004; 15;219(1-2):15-21.

  48. Stojkovic T, de Seze J, Hurtevent JF, Arndt C, Beaume A, Hache JC, et al. Visual evoked potentials study in chronic idiopathic inflammatory demyelinating polyneuropathy. Clin Neurophysiol 2000;111(12):2285-91.

  49. Uncini A, Gallucci M, Lugaresi A, Porrini AM, Onofrj M, Gambi D.CNS involvement in chronic inflammatory demyelinating polyneuropathy: an electrophysiological and MRI study. Electromyogr Clin Neurophysiol 1991;31(6):365-71.

  50. Said G. Chronic inflammatory demyelinating polyneuropathy. Neuromuscul Disord 2006;16(5):293-303.

  51. Molenaar DS, Vermeulen M, de Haan R. Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 1998;64:84-9.

  52. Gabriel CM, Howard R, Kinsella N. Prospective study of the usefulness of sural nerve biopsy. J Neurol Neurosurg Psychiatry 2000;69:442-6.

  53. Bosboom WM, van den Berg LH, Franssen H. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy. Brain 2001; 124:2427-38.

  54. Sommer C, Koch S, Lammens M, Gabreels-Festen A, Stoll G, Toyka KV. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP. Neurology 2005; 65(12):1924-9.

  55. Haq RU, Fries TJ, Pendlebury WW, Kenny MJ, Badger GJ, Tandan R. Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria. Arch Neurol 2000;57: 1745-50.

  56. Vallat JM, Tabaraud F, Magy L. Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases. Muscle Nerve 2003;27:478-85.

  57. Bouchard C, Lacroix C, Plante V. Clinicopathologic tindings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 1999;52:498-503.

  58. Gorson KC, Ropper AH. Chronic inflammatory demyelinating polyneuropathy (CIDP): a review of clinical syndromes and treatment approaches in clinical practice. J Clin Neuromuscul Dis 2003;4: 174-9.

  59. Hahn AF, Bolton CF, Zochodne D, Feasby TE. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebocontrolled, crossover study. Brain 1996;119:1067-77.

  60. Mendell JR, Barohn RJ, Freimer ML. Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 2001; 56:445-9.

  61. Hahn AF, Bolton CF, Pillay N. Plasma- exchange therapy in chronic inftammatory demyelinating polyneuropathy: a doubleblind, sham-controlled, cross-over study. Brain 1996;119: 1055-66.

  62. Hughes R, Bensa S, Willison H. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001;50: 195-201.

  63. Dyck PJ, Litchy WJ, Kratz KM. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 1994;36:838 45.

  64. Hahn AF, Bolton CF, Pillay N. Plasma exchange therapy in CIDP. Brain 1996;119:1055-66.

  65. De Sousa EA, Brannagan TH 3rd. Diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy. Curr Treat Options Neurol 2006;8(2):91-103.




2020     |     www.medigraphic.com